APA (7th ed.) Citation

Wang, L., Ma, S., Malhi, L. R., Wu, X., Liu, L., Wan, X., . . . Ge, S. (2025). Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates. Elsevier.

Chicago Style (17th ed.) Citation

Wang, Liang, Shipeng Ma, Lajpat Rai Malhi, Xiaoping Wu, Liping Liu, Xin Wan, Yuliang Zhang, Xiaopeng Li, and Shanfei Ge. Improvement in Renal Function After Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B Patients with Low Estimated Glomerular Filtration Rates. Elsevier, 2025.

MLA (9th ed.) Citation

Wang, Liang, et al. Improvement in Renal Function After Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B Patients with Low Estimated Glomerular Filtration Rates. Elsevier, 2025.